Femasys shares rise 13.18% after-hours after Nasdaq grants 180-day extension to meet bid price requirement.

Femasys Inc. (NASDAQ: FEMY) surged 13.18% in after-hours trading following the announcement that Nasdaq granted the company an 180-day extension to regain compliance with the minimum $1.00 bid price requirement, extending the deadline to July 13, 2026. The extension allows Femasys to either raise its share price to the threshold for ten consecutive business days or implement a reverse stock split to address the deficiency. This development removes immediate delisting risks, providing the company additional time to stabilize its stock price while it advances its fertility and non-surgical birth control product commercialization. The news, repeated across multiple reports, directly aligns with the stock’s sharp after-hours rally, reflecting investor optimism over the regulatory reprieve and the company’s compliance roadmap.